NASDAQ:ORGO

Organogenesis Holdings . Class A Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy ORGO

*Your capital is at risk

$2.33

+0.0900 (+4.02%)

At Close: Jun 03, 2026

Organogenesis Holdings . Class A Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -1.53. In total, the insiders bought 4.47M and sold 1.37M ORGO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-1.53
● Buy	4.47M shares
● Sell	1.37M shares
48% Buy Activity Moderate Positive Correlation
Buy Signal Low Confidence Feb 18, 2026 Analysis Breakdown: Weakened by a contradictory negative Insider Power Score. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 09, 2026 Buy	Class A Common Stock P-Purchase	Leibowitz Arthur S Director	Director	5 000 Value: $13.4K
Mar 09, 2026 Buy	Class A Common Stock P-Purchase	Driscoll Michael Joseph Director	Director	10 000 Value: $26.7K
Mar 01, 2026 Sell	Class A Common Stock F-InKind	Cavorsi Robert Vice President, Strategy	CEO / President	700 Value: $2K
Feb 18, 2026 Buy	Class A Common Stock A-Award	Freedman Lori Chief Admin. And Legal Officer	Officer	43 212 Value: $165.9K
Feb 18, 2026 Sell	Class A Common Stock F-InKind	Cavorsi Robert Vice President, Strategy	CEO / President	5 487 Value: $21.1K
Feb 18, 2026 Buy	Class A Common Stock A-Award	Francisco David Chief Financial Officer	C-Suite Officer	44 040 Value: $169.1K
Feb 18, 2026 Buy	Class A Common Stock A-Award	Bilbo Patrick Chief Operating Officer	C-Suite Officer	49 102 Value: $188.6K
Feb 18, 2026 Buy	Class A Common Stock A-Award	Grow Brian Chief Commercial Officer	Officer	48 818 Value: $187.5K
Feb 18, 2026 Sell	Class A Common Stock F-InKind	Gillheeney Gary S. President And CEO	CEO / President	91 311 Value: $350.6K
Feb 18, 2026 Buy	Class A Common Stock A-Award	Gillheeney Gary S. President And CEO	CEO / President	188 856 Value: $725.2K
Feb 18, 2026 Sell	Class A Common Stock F-InKind	Montecalvo Antonio S. Vice President, Health Policy	CEO / President	3 778 Value: $14.5K
Feb 18, 2026 Buy	Class A Common Stock A-Award	Montecalvo Antonio S. Vice President, Health Policy	CEO / President	11 330 Value: $43.5K
Feb 18, 2026 Sell	Class A Common Stock F-InKind	Grow Brian Chief Commercial Officer	Officer	11 887 Value: $45.6K
Feb 18, 2026 Sell	Class A Common Stock F-InKind	Bilbo Patrick Chief Operating Officer	C-Suite Officer	16 375 Value: $62.9K
Feb 18, 2026 Sell	Class A Common Stock F-InKind	Francisco David Chief Financial Officer	C-Suite Officer	14 687 Value: $56.4K
Feb 18, 2026 Buy	Class A Common Stock A-Award	Cavorsi Robert Vice President, Strategy	CEO / President	16 454 Value: $63.2K
Feb 18, 2026 Sell	Class A Common Stock F-InKind	Freedman Lori Chief Admin. And Legal Officer	Officer	14 411 Value: $55.3K
Feb 18, 2026 Buy	Class A Common Stock	Mcguire Patrick Chief Accounting Officer	Officer	0 Value: $0
Feb 18, 2026 Buy	Class A Common Stock	Mcguire Patrick Chief Accounting Officer	Officer	0 Value: $0
Feb 18, 2026 Buy	Class A Common Stock	Mcguire Patrick Chief Accounting Officer	Officer	0 Value: $0
Feb 18, 2026 Buy	Class A Common Stock A-Award	Korfin Michele Ilene Director	Director	48 828 Value: $187.5K
Feb 18, 2026 Buy	Class A Common Stock A-Award	Lustig Garrett Director	Director	48 828 Value: $187.5K
Feb 18, 2026 Buy	Class A Common Stock A-Award	Duraibabu Prathyusha Director	Director	48 828 Value: $187.5K
Feb 18, 2026 Buy	Class A Common Stock A-Award	Quintero Gilberto Director	Director	48 828 Value: $187.5K
Feb 18, 2026 Buy	Stock Option (Right to Buy) A-Award	Montecalvo Antonio S. Vice President, Health Policy	CEO / President	23 162 Value: $88.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ORGANOGENESIS HOLDINGS INC. CLASS A

Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy ...

Read Full Profile Here